Related Experiment Video
Updated: Aug 14, 2026
09:13
Using Reverse Genetics to Manipulate the NSs Gene of the Rift Valley Fever Virus MP-12 Strain to Improve Vaccine Safety and Efficacy
Published on: November 1, 2011
Separating the factors in measles vaccine failure
Annals of Tropical Paediatrics
|June 1, 1985
Summary
Measles vaccine failure in infants is often due to not developing immunity (failure to seroconvert), especially in younger babies. Misdiagnosis also contributes significantly to vaccine failure rates.
Area of Science:
- Immunology
- Vaccinology
- Pediatric Infectious Diseases
Background:
- Measles vaccination is crucial for public health, but high failure rates have been observed.
- Understanding the causes of measles vaccine failure is essential for improving immunization program effectiveness.
Purpose of the Study:
- To investigate the primary reasons for measles vaccine failure in a specific population.
- To differentiate the contributions of maternal antibodies, vaccine viability, and misdiagnosis to vaccine failure.
Main Methods:
- A study was conducted at Oguntolu Street Clinic, Lagos, between October 1982 and February 1983.
- The study assessed factors including circulating maternal antibodies, vaccine viability, and diagnostic accuracy.
Main Results:
- Failure to seroconvert was identified as the leading cause of measles vaccine failure (67.7%), particularly in infants aged 6-7 months.
- Incorrect diagnosis accounted for 32.3% of vaccine failures.
- Administration of non-viable vaccine was ruled out as a cause, as all measles vaccine vials were confirmed potent.
Conclusions:
- Failure to seroconvert is the predominant reason for measles vaccine failure in the studied population, especially in younger infants.
- Misdiagnosis represents a significant, yet secondary, factor contributing to measles vaccine failure.
- Ensuring vaccine viability is critical, but immunological response and accurate diagnosis are key to successful measles immunization.
